Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Acura Pharmaceuticals Cash and Short Term Investments (Quarterly): 0.089M for Sept. 30, 2021
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | 0.065M |
September 30, 2021 | 0.089M |
June 30, 2021 | 0.167M |
March 31, 2021 | 0.361M |
December 31, 2020 | 0.413M |
September 30, 2020 | 0.493M |
June 30, 2020 | 1.038M |
March 31, 2020 | 1.21M |
December 31, 2019 | 0.862M |
September 30, 2019 | 0.615M |
June 30, 2019 | 0.015M |
March 31, 2019 | 0.095M |
December 31, 2018 | 0.091M |
September 30, 2018 | 0.018M |
June 30, 2018 | 0.568M |
March 31, 2018 | 0.774M |
December 31, 2017 | 2.22M |
September 30, 2017 | 4.787M |
June 30, 2017 | 1.079M |
March 31, 2017 | 3.843M |
December 31, 2016 | 2.681M |
September 30, 2016 | 4.272M |
June 30, 2016 | 6.781M |
March 31, 2016 | 10.97M |
December 31, 2015 | 10.84M |
Date | Value |
---|---|
September 30, 2015 | 15.25M |
June 30, 2015 | 10.92M |
March 31, 2015 | 14.21M |
December 31, 2014 | 12.10M |
September 30, 2014 | 14.56M |
June 30, 2014 | 17.36M |
March 31, 2014 | 22.49M |
December 31, 2013 | 26.07M |
September 30, 2013 | 19.43M |
June 30, 2013 | 19.47M |
March 31, 2013 | 23.45M |
December 31, 2012 | 27.42M |
September 30, 2012 | 29.32M |
June 30, 2012 | 31.16M |
March 31, 2012 | 33.21M |
December 31, 2011 | 35.68M |
September 30, 2011 | 37.66M |
June 30, 2011 | 39.50M |
March 31, 2011 | 21.63M |
December 31, 2010 | 24.04M |
September 30, 2010 | 25.87M |
June 30, 2010 | 27.01M |
March 31, 2010 | 27.36M |
December 31, 2009 | 30.17M |
September 30, 2009 | 32.73M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.015M
Minimum
Jun 2019
1.21M
Maximum
Mar 2020
0.4844M
Average
0.413M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.13M |
Palatin Technologies Inc | 9.485M |
iBio Inc | 2.788M |
Theriva Biologics Inc | 23.18M |
Oragenics Inc | 3.484M |